- Home
- BLMN vs RCKT Comparison
BLMN vs RCKT Comparison
Compare BLMN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLMN
- RCKT
- Stock Information
- Founded
- BLMN 1988
- RCKT 1999
- Country
- BLMN United States
- RCKT United States
- Employees
- BLMN N/A
- RCKT N/A
- Industry
- BLMN Restaurants
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BLMN Consumer Discretionary
- RCKT Health Care
- Exchange
- BLMN Nasdaq
- RCKT Nasdaq
- Market Cap
- BLMN 1.7B
- RCKT 1.9B
- IPO Year
- BLMN 2012
- RCKT N/A
- Fundamental
- Price
- BLMN $17.00
- RCKT $19.61
- Analyst Decision
- BLMN Hold
- RCKT Strong Buy
- Analyst Count
- BLMN 9
- RCKT 9
- Target Price
- BLMN $22.33
- RCKT $53.22
- AVG Volume (30 Days)
- BLMN 1.3M
- RCKT 638.8K
- Earning Date
- BLMN 11-01-2024
- RCKT 11-04-2024
- Dividend Yield
- BLMN 5.74%
- RCKT N/A
- EPS Growth
- BLMN N/A
- RCKT N/A
- EPS
- BLMN 0.35
- RCKT N/A
- Revenue
- BLMN $4,588,223,000.00
- RCKT N/A
- Revenue This Year
- BLMN N/A
- RCKT N/A
- Revenue Next Year
- BLMN $3.05
- RCKT $300.20
- P/E Ratio
- BLMN $47.51
- RCKT N/A
- Revenue Growth
- BLMN 0.88
- RCKT N/A
- 52 Week Low
- BLMN $15.20
- RCKT $16.55
- 52 Week High
- BLMN $30.13
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- BLMN 48.61
- RCKT 52.76
- Support Level
- BLMN $15.48
- RCKT $18.65
- Resistance Level
- BLMN $17.64
- RCKT $20.10
- Average True Range (ATR)
- BLMN 0.62
- RCKT 0.85
- MACD
- BLMN 0.00
- RCKT 0.24
- Stochastic Oscillator
- BLMN 67.22
- RCKT 89.17
About BLMN Bloomin' Brands Inc.
Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabbas. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S. while restaurants operating outside the U.S. are included in the international segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.